Stockreport

Health Care Roundup: Market Talk [Yahoo! Finance]

Tourmaline Bio, Inc.  (TRML) 
PDF 0409 ET – Novartis's $1.4 billion deal to buy Tourmaline Bio looks like a strategically meaningful move that is set to complement its cardiovascular-treatment pipeline, [Read more]